Research progress on the comorbidity mechanism of sarcopenia and obesity in the aging population.
- Author:
Hao-Dong TIAN
1
;
Yu-Kun LU
1
;
Li HUANG
1
;
Hao-Wei LIU
1
;
Hang-Lin YU
1
;
Jin-Long WU
1
;
Han-Sen LI
2
;
Li PENG
1
Author Information
- Publication Type:English Abstract
- MeSH: Humans; Sarcopenia/physiopathology*; Obesity/physiopathology*; Aging/physiology*; Autophagy/physiology*; Insulin Resistance; Comorbidity; Vitamin D/metabolism*; Gonadal Steroid Hormones/metabolism*; Gastrointestinal Microbiome; Mitochondria; MicroRNAs
- From: Acta Physiologica Sinica 2025;77(5):905-924
- CountryChina
- Language:Chinese
- Abstract: The increasing prevalence of aging has led to a rising incidence of comorbidity of sarcopenia and obesity, posing significant burdens on socioeconomic and public health. Current research has systematically explored the pathogenesis of each condition; however, the mechanisms underlying their comorbidity remain unclear. This study reviews the current literature on sarcopenia and obesity in the aging population, focusing on their shared biological mechanisms, which include loss of autophagy, abnormal macrophage function, mitochondrial dysfunction, and reduced sex hormone secretion. It also identifies metabolic mechanisms such as insulin resistance, vitamin D metabolism abnormalities, dysregulation of iron metabolism, decreased levels of nicotinamide adenine dinucleotide, and gut microbiota imbalances. Additionally, this study also explores the important role of genetic factors, such as alleles and microRNAs, in the co-occurrence of sarcopenia and obesity. A better understanding of these mechanisms is vital for developing clinical interventions and preventive strategies.
